PermRock Royalty Trust
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- PermRock Royalty Trust (NYSE: PRT) operates as a Delaware statutory trust that owns an 80% net profits interest in oil and natural gas producing properties located in the Permian Basin of West Texas, including overriding royalty interests, fee mineral interests, and net profits interests in crude oil, natural gas, and natural gas liquids production from approximately 22,394 net acres primarily in Reeves and Loving counties in the Delaware Basin and other areas such as the Permian Shelf and Crane County; the Trust collects monthly net proceeds from these interests, deducts administrative expenses and cash reserves, and distributes the remaining cash flow to unitholders on a monthly basis. The Trust does not engage in drilling, operations, or development activities, relying instead on third-party operators for production from the underlying properties. Established in 2017 by Boaz Energy II, LLC as Trustor with Argent Trust Company as Trustee (effective December 30, 2022) and Wilmington Trust, National Association as Delaware Trustee, headquartered at 3838 Oak Lawn Avenue, Suite 1720, Dallas, Texas, the Trust targets investors seeking passive exposure to Permian Basin royalty income streams without operational risk. In a major development, Boaz Energy and Boaz Energy II Royalty, LLC sold the underlying properties to T2S Permian Acquisition II LLC (T2S) via a Purchase and Sale Agreement announced January 10, 2025, and closed on March 31, 2025, with T2S assuming operations as successor-in-interest and revising the 2025 development plan to defer certain drilling in Crane County amid commodity price volatility while advancing workovers, waterflood optimization, shut-in well reactivations, and a non-operated well in the Permian Shelf completed in Q3 2025. The Trust continues monthly cash distributions, including $0.031565 per unit declared November 17, 2025, based on August 2025 production, reflecting ongoing focus on net profits distribution under T2S management.
Company News
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
PermRock Royalty Trust (NYSE:PRT) Shares Down 1.1% – Here’s Why
PermRock Royalty Trust (PRT) To Go Ex-Dividend on September 30th
PermRock Royalty Trust Declares Monthly Cash Distribution
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
PermRock Royalty Trust Declares Monthly Cash Distribution
PermRock Royalty Trust Declares Monthly Cash Distribution
PermRock Royalty Trust Declares Monthly Cash Distribution
PermRock Royalty Trust Declares Monthly Cash Distribution
The structural problem no oil price recovery can fix for PRT investors
PermRock Royalty Trust Declares Monthly Cash Distribution
Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026
PermRock Royalty Trust Declares Monthly Cash Distribution
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026
PermRock Royalty Trust Declares Monthly Cash Distribution
These $5 Stocks and ETFs Are Paying Huge Yields to 12%, but There's a Catch
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
PermRock Royalty Trust Declares Monthly Cash Distribution
LARGE CAP INTERNATIONAL PORTFOLIO Buys 594 Shares of Brookfield Wealth Solutions Ltd (BNT)